Investor Relations

Corporate Information
Corporate Governance
and Responsibility
News and Events
News Releases
In the News
Future Events
Past Events & Presentations
Stock Information &
Investor Tools
Financial Information
Tax Cost Basis
SEC Filings
Annual Reports
Quarterly Snapshot
Historical Financial Tables
Shareholder Services
2008 Proxy Statement
Stock Transfer Agent
Electronic Delivery Enrollment
Investor FAQs
Contact Information

Tax Cost Basis

On April 1, 2000, Edwards Lifesciences spun off from Baxter. At this time, shareholders were given 1 Edwards share for every 5 shares of Baxter stock. Below is some information to assist you in computing the tax basis. However, since individual situations vary greatly based on specific financial conditions, we recommend you contact your accountant or tax professional for the latest reporting guidelines appropriate to you.

Computation of Tax Basis

March 31, 2000

Baxter
(Regular Way)

Edwards Lifesciences (When Issued)

Closing price on the
New York Stock
Exchange

$62.6875

$13.5625

 

Mar. 31, 2000
Per Share
Market Value(1)

Value Adjusted
Per Previous
Share of Baxter Common(2)

Adjusted Values as a Percent of
Total(3)

Multiplier to
Determine New Per Share Cost
Basis(4)

Baxter
Common Stock

$62.6875

$59.9750

0.95673

0.95673

Edwards Lifesciences
Common Stock

$13.5625

$2.7125

0.04327

0.21635

TOTAL

 

$62.6875

1.00000

 

To calculate the cost basis of your Baxter stock (BAX):

Multiply the original total cost of your Baxter stock by 0.95673 (or 95.673%). The result is the new cost basis of your Baxter stock. (To calculate the cost basis per share, please see the ratios under Multiplier to Determine New Per Share Cost Basis found in the table above.)

To calculate the cost basis of your Edwards Lifesciences stock (EW):

Multiply the original total cost of your Baxter stock by 0.04327 (or 4.327%). The result is the new cost basis of your Edwards Lifesciences stock. (To calculate the cost basis per share, please see the ratios under Multiplier to Determine New Per Share Cost Basis found in the table above.)

(1) The closing market price for each stock on March 31. The closing market price of Baxter common stock trading regular way. The closing market price of Edwards common stock trading when issued.

(2) Since Edwards shares are being distributed on a 1-for-5 basis, the per share market values must be adjusted by dividing by five (5) and the Baxter shares must be adjusted to reflect the value without the value of the Edwards shares.

(3) These fractions represent the $59.9750 value of one share of Baxter common stock and the $2.7125 value of one-fifth (1/5) share of Edwards common stock received for one (1) share of Baxter common stock, in relation to the sum of such values, $62.6875.

(4) Multiplier applicable to the previous per share tax basis for Baxter common stock to determine the new per share cost basis for each (Baxter and Edwards) stock. This multiplier is determined by multiplying the percentage in column 3 for Baxter by one (1) for one full share of Baxter stock and the percentage in column 3 by five (5) to determine a full share of Edwards common stock.

 

Contact Us  | Legal Terms | Privacy Policy | © 2008 Edwards Lifesciences LLC. All rights reserved.